tiprankstipranks
Trending News
More News >
Kyverna Therapeutics, Inc. (KYTX)
:KYTX
US Market

Kyverna Therapeutics, Inc. (KYTX) Income Statement

Compare
886 Followers

Kyverna Therapeutics, Inc. Income Statement

Last quarter (Q3 2025), Kyverna Therapeutics, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Kyverna Therapeutics, Inc.'s net income was $-36.79M. See Kyverna Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 7.03M$ 5.66M
Gross Profit
$ -2.13M$ -1.71M$ 7.03M$ 5.66M
Operating Expenses
$ 140.47M$ 60.70M$ 36.41M$ 32.00M
Depreciation and Amortization
$ 2.13M$ 1.71M$ 1.05M$ 586.00K
EBITDA
$ -125.20M$ -58.47M$ -27.78M$ -25.76M
Operating Income
$ -142.60M$ -62.41M$ -29.38M$ -26.35M
Other Income/Expenses
$ 15.13M$ 2.04M$ 491.00K$ -4.00K
Pretax Income
$ -127.48M$ -60.37M$ -28.89M$ -26.35M
Net Income
$ -127.48M$ -60.37M$ -28.89M$ -26.35M
Per Share Metrics
Basic EPS
$ -3.33$ 0.00$ -1.12$ -1.02
Diluted EPS
$ -3.33$ 0.00$ -1.12$ -1.02
Weighted Average Shares Outstanding
38.33M 673.62M 25.80M 25.80M
Weighted Average Shares Outstanding (Diluted)
38.33M 673.62M 25.80M 25.80M
Currency in USD

Kyverna Therapeutics, Inc. Earnings and Revenue History